ProShare Advisors’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$221K Sell
6,214
-257
-4% -$10.1K ﹤0.01% 1515
2026
Q2
$300K Buy
+6,471
New +$233K ﹤0.01% 1415
2025
Q4
– Sell
-7,724
Closed -$219K – 2102
2025
Q3
$219K Sell
7,724
-1,397
-15% -$37.9K ﹤0.01% 1646
2025
Q2
$227K Sell
9,121
-999
-10% -$28.1K ﹤0.01% 1642
2025
Q1
$314K Sell
10,120
-2,836
-22% -$94.5K ﹤0.01% 1381
2024
Q4
$409K Buy
12,956
+3,996
+45% +$190K ﹤0.01% 1403
2024
Q3
$519K Buy
8,960
+2,303
+35% +$113K ﹤0.01% 1110
2024
Q2
$270K Sell
6,657
-2,061
-24% -$81.7K ﹤0.01% 1362
2024
Q1
$366K Buy
8,718
+703
+9% +$27.4K ﹤0.01% 1288
2023
Q4
$307K Buy
8,015
+1,513
+23% +$50.4K ﹤0.01% 1351
2023
Q3
$201K Sell
6,502
-122
-2% -$4.21K ﹤0.01% 1466
2023
Q2
$209K Buy
6,624
+975
+17% +$33.4K ﹤0.01% 1511
2023
Q1
$206K Buy
+5,649
New +$198K ﹤0.01% 1429
2022
Q4
– Sell
-5,361
Closed -$209K – 1896
2022
Q3
$209K Sell
5,361
-105
-2% -$4.81K ﹤0.01% 1387
2022
Q2
$212K Sell
5,466
-2,919
-35% -$111K ﹤0.01% 1438
2022
Q1
$406K Sell
8,385
-1,038
-11% -$53.5K ﹤0.01% 1429
2021
Q4
$693K Buy
9,423
+3,622
+62% +$298K ﹤0.01% 1243
2021
Q3
$528K Sell
5,801
-3,968
-41% -$337K ﹤0.01% 1180
2021
Q2
$614K Buy
+9,769
New +$361K ﹤0.01% 1377

Other funds holding ASTH

ProShare Advisors's ASTH Position: Q3 2026 in Review

ProShare Advisors reduced its Astrana Health (ASTH) stake by 4% in Q3 2026, selling an estimated $10.1K and leaving 6,214 shares worth $221K. The position accounts for ﹤0.01% of the portfolio, ranked #1515.

ProShare Advisors first reported a position in ASTH in Q2 2021 and has held it in 19 quarters since. The position peaked at $693K in Q4 2021. 96 funds tracked by Wall St. Rank hold ASTH as of Q3 2026.

  • ProShare Advisors held 6,214 shares of Astrana Health worth $221K as of Q3 2026.
  • ProShare Advisors sold 257 Astrana Health shares in Q3 2026, an estimated $10.1K.
  • Astrana Health made up ﹤0.01% of ProShare Advisors's portfolio in Q3 2026, its #1515 holding.
  • ProShare Advisors first reported a position in Astrana Health in Q2 2021 and has held it in 19 quarters since.
  • ProShare Advisors's Astrana Health position peaked at $693K in Q4 2021.
  • 96 funds tracked by Wall St. Rank held Astrana Health as of Q3 2026.

Based on ProShare Advisors's 13F filing for Q3 2026, filed 29 Oct 2026.